National Health Investors Stock Forecast
NYSE: NHIReal EstateReal Estate Investment TrustsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 66.07 +1.88%
NHI analyst consensus
Consensus (8 analysts)
buy
Avg. price target
$81.88+26.26%
- Strong buy 0
- Buy 5
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering National Health Investors (2026-10-08), 5 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $81.88, with a high estimate of $90.00 and a low estimate of $73.00. The average target implies upside of 26.3% from the current price of $64.85.
The spread between the highest and lowest targets is 23.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NHI.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 5 | 63% |
| Hold | 3 | 38% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $73.00 | +12.57% |
| Average target | $81.88 | +26.26% |
| High target | $90.00 | +38.78% |